Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of HLA-Class I monoclonal antibody, clone W6/32 (Biotin)
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Bovine,Cat,Human,Primates |
| Host species | Mouse |
| Applications | Flow Cyt |
More info about HLA-Class I monoclonal antibody, clone W6/32 (Biotin)
| Brand: | Abnova |
| Reference: | MAB5082 |
| Product name: | HLA-Class I monoclonal antibody, clone W6/32 (Biotin) |
| Product description: | Mouse monoclonal antibody raised against native HLA-Class I. |
| Clone: | W6/32 |
| Isotype: | IgG2a |
| Immunogen: | Native purified HLA-Class I from membrane of human tonsil cells. |
| Form: | Liquid |
| Recommend dilutions: | Flow Cytometry (1:300) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS, pH 7.4 (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. Do not freeze. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Conjugate tag: | Biotin |
| Product type: | Primary antibodies |
| Host species: | Mouse |
| Antigen species / target species: | Human |
| Specificity: | This antibody recognizes MHC Class I molecules (MHC Class Ia) that are expressed on the surface of all human nucleated cell types. This antibody is also suitable as a positive control for HLA tissue typing and crossmatching. |
| Reactivity: | Bovine,Cat,Human,Primates |
| Applications: | Flow Cyt |
| Shipping condition: | Blue Ice |
| Publications: | Residue 3 of beta2-microglobulin affects binding of class I MHC molecules by the W6/32 antibody.Ladasky JJ, Shum BP, Canavez F, Seuanez HN, Parham P. Immunogenetics. 1999 Apr;49(4):312-20. |